Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8807239 | 1.00 | MMP1 (0.43) | MMP1MMP9ELANERXFP1 | |
| SCHEMBL8807243 | 1.00 | MMP1 (0.43) | MMP1MMP9ELANERXFP1 | |
| SCHEMBL7172605 | 1.00 | MMP1 (0.43) | MMP1MMP9ELANERXFP1 | |
| SCHEMBL8888422 | 1.00 | MMP1 (0.43) | MMP1MMP9ELANERXFP1 | |
| SCHEMBL8810562 | 0.86 | MMP1 (0.43) | MMP1MMP9ELANERXFP1 | |
| SCHEMBL8810567 | 0.86 | MMP1 (0.43) | MMP1MMP9ELANERXFP1 | |
| SCHEMBL8810870 | 0.86 | MMP1 (0.43) | MMP1MMP9ELANERXFP1 | |
| SCHEMBL686701 | 0.84 | ELANE (0.33) | ELANE | |
| SCHEMBL679070 | 0.82 | RAB9A (0.44) | — | |
| SCHEMBL4967038 | 0.82 | RAB9A (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1499620-B1 | PROCESS FOR PREPARING 6-ALKYLIDENE PENEM DERIVATIVES | WYETH CORP (US) | 2010-01-27 | — | — | EP | disclosed |
| EP-1499620-A1 | PROCESS FOR PREPARING 6-ALKYLIDENE PENEM DERIVATIVES | Wyeth (US) | 2005-01-26 | — | — | EP | disclosed |
| US-20040132708-A1 | Process for preparing 6-alkylidene penem derivatives | WYETH | 2004-07-08 | — | — | US | disclosed |
| US-20040053913-A1 | Process for preparing 6-alkylidene penem derivatives | WYETH | 2004-03-18 | — | — | US | disclosed |
| WO-2003093277-A1 | PROCESS FOR PREPARING 6-ALKYLIDENE PENEM DERIVATIVES | WYETH (US) | 2003-11-13 | — | — | WO | disclosed |
| EP-0758240-B1 | PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | SMITHKLINE BEECHAM PLC (GB) | 2003-10-29 | — | — | EP | disclosed |
| US-6600035-B1 | Multistage reaction of forming penicillin antibiotics | SMITHKLINE BEECHAM P.L.C. (GB) | 2003-07-29 | — | — | US | disclosed |
| US-6472383-B1 | Pharmaceutical formulations | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-10-29 | — | — | US | disclosed |
| EP-0666862-B1 | 6-(SUBSTITUTED METHYLENE) PENEMS AND INTERMEDIATES | SMITHKLINE BEECHAM PLC (GB) | 2000-04-19 | — | — | EP | disclosed |
| US-6037469-A | BETA LACTAMASE INHIBITOR AND ANTIBACTERIAL; FOR TREATING BACTERIAL INFECTIONS IN HUMANS AND ANIMALS | SMITHKLINE BEECHAM PLC (GB) | 2000-03-14 | — | — | US | disclosed |
| US-5939066-A | TREATING OR PREVENTING A BACTERIAL INFECTION BY ADMINISTERING A LACTAMASE INHIBITORY EFFECTIVE AMOUNT OF A PENEM AND A LACTAM ANTIBIOTIC | SMITHKLINE BEECHAM P.L.C. | 1999-08-17 | — | — | US | disclosed |
| US-5911985-A | IN COMBINATION WITH CARRIERS AND A LACTAM ANTIBIOTIC | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-06-15 | — | — | US | disclosed |
| US-5776455-A | PENICILLIN BACTERICIDES | SMITHKLINE BEECHAM P.L.C. (GB) | 1998-07-07 | — | — | US | disclosed |
| EP-0232966-B1 | Process for the preparation of penem compounds and intermediates for this preparation | BEECHAM GROUP PLC (GB) | 1997-10-08 | — | — | EP | disclosed |
| EP-0758240-A1 | PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | SMITHKLINE BEECHAM PLC (GB) | 1997-02-19 | — | — | EP | disclosed |
| US-5602250-A | ANTIBIOTICS, BETA-LACTAMASE INHIBITORS | SMITHKLINE BEECHAM P.L.C. (GB) | 1997-02-11 | — | — | US | disclosed |
| WO-1995028935-A1 | PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | SMITHKLINE BEECHAM PLC (GB) | 1995-11-02 | — | — | WO | disclosed |
| EP-0666862-A1 | 6-(SUBSTITUTED METHYLENE) PENEMS AND INTERMEDIATES | SMITHKLINE BEECHAM PLC (GB) | 1995-08-16 | — | — | EP | disclosed |
| WO-1994010178-A1 | 6-(SUBSTITUTED METHYLENE) PENEMS AND INTERMEDIATES | SMITHKLINE BEECHAM P L C (GB) | 1994-05-11 | — | — | WO | disclosed |
| EP-0232966-A1 | Process for the preparation of penem compounds and intermediates for this preparation | BEECHAM GROUP PLC (GB) | 1987-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132708-A1 | Process for preparing 6-alkylidene penem derivatives | PGM2, BPGM, MRPL21 | MMP1 1725/4885MMP9 1643/4885ELANE 127/4885 |
| US-20040053913-A1 | Process for preparing 6-alkylidene penem derivatives | PGM2, BPGM, MRPL21 | MMP1 1725/4885MMP9 1643/4885ELANE 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.